New drug shows promise for dialysis Patients' hormone imbalance
NCT ID NCT06434961
Summary
This study tested whether a new drug called SHR6508 could safely and effectively treat a serious hormone imbalance (secondary hyperparathyroidism) in people with kidney failure who are on regular dialysis. It involved 498 participants in China and compared the drug's effects to a placebo. The main goal was to see if the drug could significantly lower the levels of a specific hormone (iPTH) in the blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SECONDARY HYPERPARATHYROIDISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, 510000, China
Conditions
Explore the condition pages connected to this study.